ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic

By sjmartinez • October 31, 2024

Keshtkar-Jahromi M, Anstrom KJ, Barkauskas C, Brown SM, Daar ES, Fischer W, Gibbs KW, Higgs ES, Hughes MD, Jagannathan P, LaVange L, Lindsell CJ, Nayak SU, Paredes R, Parmar M, Peltan ID, Proschan M, Shotwell MS, Vock DM, Yokum T, Adam SJ. ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemic. J Clin Transl Sci. 2024 Oct 15;8(1):e151. doi: 10.1017/cts.2024.1. PMID: 39478775; PMCID: PMC11523015.

Tags: ACTIV, Clinical Trial, covid-19, design, Infectious Diseases, lessons, Publications

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV

Abelman RA, Ma Y, Margolick JB, Erlandson KM, Greene M, Suskind AM, Taylor T, Rinaldo CR, Floris-Moore M, Chew KW, French AL, Markland AD, Stosor[...]

Enabling Ciprofloxacin Resistance-Guided Therapy for Neisseria gonorrhoeae: Aligning Diagnostics, Regulation, Guidelines, and Reimbursement

Trainor BW, Osborn JL, Klausner JD, Satlin MJ, Buss SN, Scheffer-Wong A, Harris A, Van Der Pol B, Deal C, Nenninger A, Mokany E, Moon[...]

Changes in attitudes toward the HPV vaccine in Kenya

Moucheraud C, Miao J, Ochieng E, Zhang S, Ganda G, Golub G, Hoffman RM, Szilagyi PG, Suen SC. Changes in attitudes toward the HPV vaccine[...]